ArticleFrontiers in oncology2021

MAPK-RAP1A Signaling Enriched in Hepatocellular Carcinoma Is Associated With Favorable Tumor-Infiltrating Immune Cells and Clinical Prognosis.

Hailin Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.